Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 2

Status

Recruiting 6Completed 3

Sponsor Class

OTHER 5NETWORK 1

Study Type

Interventional 4Observational 2

Sponsor

Cancer Type

Gastrointestinal 6Sarcoma 1

Conditions

Pancreatic Neoplasms 3Pancreatic Cystic Neoplasm 1Gastrointestinal Stromal Tumor of Stomach 1Esophageal Neoplasms 1

Interventions

Specimen Handling 480pembrolizumab 455Magnetic Resonance Spectroscopy 420Carboplatin 327Cyclophosphamide 314Cisplatin 271Biopsy 271Radiotherapy 244Paclitaxel 229Gemcitabine 227Bevacizumab 213Nivolumab 188fludarabine 185venetoclax 174Drug Therapy 170Blood Specimen Collection 158Dexamethasone 157Oxaliplatin 154Injections 152Capecitabine 151Fluorouracil 144Docetaxel 144Radiosurgery 137Standard of Care 135Rituximab 125Pemetrexed 117durvalumab 115Leucovorin 109atezolizumab 107Radiation 106

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Recruiting × Endoscopic Ultrasound-Guided Fine Needle Aspiration × 1 year × Clear all
NCT07529483 2026-05-29

ERASE-Chemo

Ohio State University Comprehensive Cancer Center

Phase 2 Recruiting
35 enrolled
Gastrointestinal

Pancreatic Cystic Neoplasm

NCT04239573 2026-05-27

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

Eastern Cooperative Oncology Group

Phase NA Recruiting
770 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT06440174 2026-04-30

VALUE

University Hospital Southampton NHS Foundation Trust

Recruiting
160 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT06748690 2026-04-16

MCB vs EUS-FNA for Preoperative Pathological Evaluation of Gastric SMT

Peking University People's Hospital

Phase NA Recruiting
96 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumor of Stomach

NCT05961982 2026-03-23

ERASE

Ohio State University Comprehensive Cancer Center

Phase NA Recruiting
84 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT06381154 2026-01-30

Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic Cancer

Mayo Clinic

Phase 2 Recruiting
25 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡